Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - DOMAIN PARTERS VII L P
Last Updated 
21-Oct-14
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

DOMAIN PARTERS VII L P: Declared Holdings
Company/RelationshipReportedShares  Ownership
Achaogen, Inc.
Beneficial Owner (10% or more)
NasdaqGM:AKAO
(historical quotes, profile, other insiders)
17-Mar-141,987,049  Direct
Clovis Oncology, Inc.
Beneficial Owner (10% or more)
NasdaqGS:CLVS
(historical quotes, profile, other insiders)
4-Jun-132,581,745  Direct
Esperion Therapeutics, Inc.
Beneficial Owner (10% or more)
NasdaqGM:ESPR
(historical quotes, profile, other insiders)
21-Oct-142,566,935  Direct
Evoke Pharma, Inc.
Beneficial Owner (10% or more)
NasdaqCM:EVOK
(historical quotes, profile, other insiders)
30-Sep-131,114,327  Direct

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
21-Oct-14 500,000ESPR Purchase at $20 per share.
(Cost of $10,000,000)
17-Mar-14 1,987,049AKAO Acquisition (Non Open Market)
30-Sep-13 1,114,327EVOK Acquisition (Non Open Market)
1-Jul-13 1,786,012ESPR Acquisition (Non Open Market)
1-Jul-13 280,923ESPR Purchase at $14 per share.
(Cost of $3,932,922)
4-Jun-13 159,192CLVS Sale at $64.58 per share.
(Proceeds of $10,280,619)
6-Mar-13 98,349CLVS Sale at $24.51 per share.
(Proceeds of $2,410,533)
5-Mar-13 126,868CLVS Sale at $24.69 per share.
(Proceeds of $3,132,370)
4-Mar-13 24,783CLVS Sale at $24.44 per share.
(Proceeds of $605,696)

 


EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?